When compared to vemurafenib-sensitive melanoma cells, melanoblasts and both resistant melanoma cells presented gene enrichment in cell cycle regulation, DNA damage regulation, metabolism of amino acids and nucleotides, JAK–STAT and p53 signalings. This evidence concerns the gene TP53 and melanoma.